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Abstract 
Purpose: To investigate the charge-transfer (CT) reaction between cediranib (CRB) and 2, 3 - dichloro- 
5, 6- dicyano -1, 4 - benzoquinone (DDQ) and employment of the reaction as a basis for the 
development of a novel 96 - microwell spectrophotometric assay for CRB. 
Method: The reaction of CRB and DDQ was investigated in different solvents of varying dielectric 
constant and polarity index The reaction resulted in the formation of a red-colored product. 
Spectrophotometric investigations confirmed that the reaction proceeded through to the formation of a 
(CT) complex.  
Results: The molar absorptivity of the CT complex was linearly correlated with the dielectric constant 
and polarity index of the solvent; the correlation coefficients were 0.801 and 0.858, respectively. The 
association constant of the complex was 0.5 × 103 L mol−1 in 2-propanol. The reaction conditions were 
optimized for the development of the microwell assay for CRB. The assay limits of detection and 
quantitation were 6.8 and 20.6 µg/well, respectively. The assay was validated as per the guidelines of 
the International Conference on Harmonization (ICH) and successfully applied to the analysis of CRB in 
its bulk and dosage forms with good accuracy and precision.  
Conclusion: The developed assay has high throughput and consumed minimum volume of organic 
solvent; thus, it reduces the exposure of the analysts to the toxic effects of organic solvents, and should 
significantly lower the analysis cost.  
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Cediranib (CRB, Fig 1) is a novel small-molecule; 
potent inhibitor of vascular endothelial growth 
factor (VEDF) receptor tyrosine kinases [1-3]. 
Extensive literature survey revealed that only one 
liquid chromatography–mass spectrometric 
method was available for determination of CRB 
in biological fluids [4]. This fact promoted our 
interest in the development of a new method for 
quality control (QC) of CRB.  
 
The charge-transfer (CT) reaction between the 
electron-donating and electron-accepting 
molecules has considerable importance in 
different fields of chemistry [5-8]. CT reactions 
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are generally associated with the formation of 
intensely colored CT complexes, which usually 
absorb radiations; consequently, a new light 
absorption band occurs at much longer 
wavelength than in the spectra of the CT 
complex components [9]. The rapid formation of 
these complexes leads to their widespread utility 
in the development of spectrophotometric 
methods for analysis of many pharmaceutical 
molecules [10] and extensive studies involving 
CT reactions have been conducted [10 - 12]. The 
benzoquinone derivatives have π-orbitals of the 
benzoquinone ring, which have electron-
accepting ability. This ability increases with the 
introduction of electron-withdrawing groups like 
chloro-, nitro-, cyano, etc., on the benzoquinone 
ring [13]. These groups have strong 
electronegativity and large Hammett constants 
[14]. 2, 3 - dichloro- 5, 6- dicyano -1, 4 - 
benzoquinone (DDQ, Fig 1) acts as a strong π-
electron acceptor in studying the CT reactions of 
electron donors [15].  
 
The present study was devoted to the 
investigation of the CT reaction between CRB 
and DDQ and employment of the reaction as a 
basis in the development of a novel 96 - 
microwell high throughput spectrophotometric 





Chemicals and materials  
 
Cediranib (CRB) standard was obtained from 
Weihua Pharma Co. Ltd. (Zhejiang, China) and 
was used as received; the purity of the 
investigated compound was > 99 %. DDQ 
Sigma-Aldrich Corporation, (St. Louis, MO, 
USA). Solvents and excipients were of analytical 
grade (Fisher Scientific, California, CA, USA). 
 
Preparation of standard CRB solutions 
 
Into a 5 ml calibrated flask, 10 mg (2.22 × 10-5 
mole) of CRB was accurately weighed, dissolved 
in 2 ml methanol, and completed to volume with 
the same solvent. This stock solution (4.44 × 
10−3 mol L-1) was diluted with the appropriate 
solvent to obtain CRB concentrations suitable for 
the corresponding study. 
 
Determination of association constant  
 
Series of CRB solutions (0.89 × 10−4 − 5.5 × 10−4 
mol L-1) were mixed with DDQ solution of a fixed 
concentration (4.4 × 10−3 mol L-1); both CRB and 
DDQ solutions were prepared in 2 - propanol as 
this solvent gave the highest readings and was 
not harmful to the microwell-plate transparency. 
These mixed solutions were allowed to reach 
equilibrium (~5 min) at room temperature (25 ± 2 
oC). The absorbance of the solutions was 
measured at 460 nm against reagent blanks 
treated similarly. The measurements were 
conducted on UV-1601 PC double-beam ultra-
violet-visible spectrophotometer (Shimadzu, 
Kyoto, Japan). 
 
Preparation of CRB-containing dosage form 
sample solution 
 
An accurately weighed amount (45 mg) of CRB 
was mixed with the excipients: microcrystal-line 
 
 
Figure 1: The chemical structure and chemical names of cediranib (CRB) and 2, 3 - dichloro- 5, 6- dicyano -1, 4 - 
benzoquinone (DDQ) 
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cellulose (50 mg), colloidal silicon dioxide (10 
mg), anhydrous dibasic calcium phosphate (5 
mg), sodium starch glycolate (5 mg), and 
magnesium stearate (5 mg). The laboratory-
prepared sample was dissolved in 5 ml of 
methanol, swirled and sonicated for 5 min, and 
filtered. The first portion of the filtrate was 
rejected, and a measured volume of the filtrate 
was diluted with methanol to yield CRB 
concentrations in the range of 100 - 1000 µg/ml. 
These samples were analyzed by the proposed 
assay applying the microwell assay procedure. 
 
Microwell assay procedure 
 
Accurately measured aliquots (100 µL) of the 
standard or sample solution containing varying 
amounts of CRB (100 – 1000 µg/mL) were 
transferred into wells of 96 - microwell assay 
plates (Corning/Costar Inc., Cambridge, USA). 
Solutions were dispensed by adjustable 8 – 
channel - pipette (Sigma Chemical Co., St. Louis, 
MO, USA). One hundred microliters of DDQ 
solution (0.1 %, w/v) was added, and the reaction 
was allowed to proceed at room temperature (25 
± 2 oC) for 5 min. The absorbances of the 
resulting solutions were measured at 460 nm by 
the microwell-plate reader (ELx 808, Bio-Tek 
Instruments Inc. Winooski, USA) empowered by 
Gen5 software (provided with the instrument). 
Blank wells were treated similarly except 100 µL 
of methanol was used instead of the sample, and 
the absorbances of the blank wells were 




Absorption spectral characteristics 
 
The absorption spectrum of CRB solution (5.5 × 
10−4 mol L-1, in methanol) was recorded. It was 
obvious from the spectrum that CRB exhibited a 
maximum absorption peak (λmax) at 320 nm. CRB 
solution (5.5 × 10−4 M) was mixed with DDQ 
solution (4.4 × 10−3 mol L-1), and the interaction 
of CRB with DDQ was allowed to proceed at 
room temperature (25 ± 2 oC), and the 
absorption spectrum of the reaction mixture was 
recorded against DDQ reagent blank solution. A 
red-colored product was obtained showing 
absorption maximum at 460 nm, and the reaction 
went to completion very rapidly.  
 
Effect of solvent on the interaction of CRB 
with DDQ  
 
The interaction of CRB with DDQ was allowed to 
proceed in different solvents of varying dielectric 
constants and polarity indices and the absorption 
spectra were recorded. The molar absorptivity 
(Ɛ) was determined in each solvent; the obtained 
values are given in Table 1. 
 
Association constant for CRB-DDQ CT 
complex 
 
The association constant was evaluated at room 
temperature (25 ± 2 oC) and at the λmax of CRB-
DDQ complex (in 2-propanol as this solvent gave 
the highest reading and did not affect the 
transparency of the microwell of the assay plate, 
as acetrontrile did) using the Benesi-Hildebrand 
equation (Equation 1) [19]: 
 
Ao/AAD = 1/ƐAD + 1/KcAD.ƐAD × 1/Do ……… (1) 
 
where [Ao] is the molar concentration of the 
acceptor (DDQ); [Do] is the molar concentration 
of the donor (CRB); AAD is the absorbance of the 
complex formed at the λmax; ƐAD is the molar 
absorptivity of the complex; KcAD is the 
association constant of the complex (L mol−1). 
Upon plotting the values [Ao]/AAD against l/[Do], a 
straight line was obtained, from which the 
association constant, correlation coefficient, and 
the molar absorptivity (Ɛ) of the CRB–DDQ 
complex were calculated. The intercept of the 
fitting line corresponded to 1/ƐAD and the 
association constant was calculated from the 
slope value of the line and the derived value of 
ƐAD.  The molar absorptivity and association 
constant of the complex (in 2-propanol) were 
found to be 1 × 103 L mol−1 cm−1 and 0.5 × 103 L 
mol−1, respectively. The standard free energy 
change (ΔGo) of the CT complex was calculated 
and found to be 3.7 × 103 kcal mol−1. 
 
Optimization of assay conditions 
 
The optimization of experimental conditions for 
carrying out the reaction in the 96-microwell 
assay plate was investigated by altering each 
reaction variable in turn while keeping the others 
constant. The reaction was carried out in 
methanol and all the measurements were carried 
out by the plate reader at 460 nm. The studied 
conditions were: concentration of DDQ reagent, 
reaction time, and temperature. The studied 
range of these conditions and the optimum value 
that was selected for the assay development are 
given in Table 2. 
 
It is worth mentioning that methanol was 
considered as optimum solvent for carrying out 
the reaction in the microwell assay plates 
although acetonitrile gave the highest Ɛ value  
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   Table 1: Effect of solvents on the position and intensity of absorption of the reaction mixtures of CRB with DDQ 
 
 Solvent  (×103) c 
Name DEC a PI b 
Acetonitrile 37.5 5.8 3.28 
Methanol 32.7 5.1 2.87 
Ethanol 24.6 5.2 2.75 
Acetone 20.7 5.1 2.34 
2-Propanol 19.9 3.9 2.24 
Dichloromethane 10.5 3.5 2.03 
Dichloroethane 9.1 3.1 0.51 
Toluene 2.4 2.4 0.22 
Chloroform 2.2 4.8 0.10 
a DEC = dielectric constant; values were obtained from reference 18; b PI = Polarity index; values were obtained 
from reference 19: c  = molar absorptivity; values are expressed as L mol−1 cm−1 
 
(Table 1). This was because of the negative 
effect of acetonitrile on the transparency of the 
assay plate material. 
 
Validation and application of the assay 
 
Under the above mentioned optimum reaction 
conditions, the calibration curve for the analysis 
of CRB by the proposed assay was constructed. 
The regression equation for the results was de-
rived using the least-squares method. Beer’s law 
plot (10-concentration levels, n = 5) was linear in 
the range of 10 – 100 µg/well. The calibration 
equation was: A = 0.0386 + 0.0089 C (r = 
0.9995), where A, C and r are the absorbance, 
concentration of CRB (mg/well) and correlation 
coefficient, respectively (Table 3). The limits of 
detection (LOD) and quantitation (LOQ) were 
determined [25] using the formula: LOD or LOQ 
= κSDa/b, where κ = 3.3 for LOD and 10 for 
LOQ, SDa is the standard deviation of the 
intercept, and b is the slope. The LOD and LOQ 
values were 6.8 and 20.6 µg/well, respectively. 
The intra- and inter assay precisions were 
assessed at three CRB concentrations (20, 50 
and 80 µg/well). The relative standard deviation 
(RSD) values did not exceed 2 %, indicating 
good precision of the assay. This good level of 
precision was attributed to the accuracy of the 
volumes that were concomitantly dispensed in 
the microwells by multi–channel pipettes, and 
completeness of the reaction in a small volume 
(200 µL). The high-precision property of the 
assay made it suitable for its routine application 
in QC laboratories for determination of CRB 
samples (bulk and dosage forms). In addition, 
the accuracy, robustness and ruggedness of the 
assay were evaluated and all the results were 
satisfactory as per the ICH guidelines [25]. A 
summary for the quantitative and validation 
parameters of the assay is given in Table 3. The 
assay was applied to the analysis of CRB-
containing laboratory-made dosage forms. The 
mean percentage recovery, relative to the 
nominated amounts, obtained by the proposed 
assay was 98.23 ± 2.58 %. This good recovery 
values indicated the reliability of the proposed 
assay for routine application for the accurate 
determination of CRB in pharmaceutical QC 
laboratories. 
 
Table 3: Quantitative parameters for the analysis of 
CRB by the microwell spectrophotometric assay based 
on the CT reaction of CRB with DDQ 
 
Parameter  Value 
Linear range (µg/well)  10 ─ 100 
Intercept  0.0386 




Standard deviation of 
slope 
3×10─4 
Correlation coefficient  0.9995 
LOD (µg/well)  6.8 
LOQ (µg/well)  20.6 
Precision (RSD, %) < 2 
Accuracy (%)  98 
 
Table 2: Optimization of experimental conditions for 
the microwell spectrophotometric assay for CRB 
based on its formation of colored CT complex with 
DDQ 
 
Condition   Studied range Optimum 
DDQ conc. (%, w/v) 0.02 ─ 0.2 0.1 
Solvent Different a Methanol 
Reaction time (min) 2 ─ 40 5 
Temperature (C) 25 ─ 60 25 
max (nm) 400 ─ 650 460 




The results showed us that the absorption 
intensity of the new absorption maximum (460 
nm) increased with CRB concentrations in the 
interaction solution. This continuous increase in 
the absorbance of the new absorption band with 
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(the reaction time and) CRB concentrations was 
indicative of the formation of CRB - DDQ 
product. The new absorption band was attributed 
to the complete electron transfer from CRB (D) to 
DDQ (electron acceptor; A) accompanied by the 
formation of colored radical acceptor anion 
(DDQ—) [16], which was formed by the 
dissociation of an original donor-acceptor (D - A) 
complex (equation 2). 
 




radical ions………. (2) 
 
The dissociation of the (D - A) complex was 
promoted by the high ionizing power of the polar 
solvent and the resulting peak in the absorption 
spectra of the reaction mixture were similar to the 
maxima of the radical anion of the acceptor 
obtained by the iodide reduction method [16].  
 
The interaction in polar solvents with high 
dielectric constants (e.g. acetonitrile, methanol, 
ethanol, etc) produced CT complexes with Ɛ 
values higher than those produced in low-polar 
solvents with low dielectric constants (e.g. 
dichloromethane); however the reaction did not 
proceed at all in non-polar solvent (e.g. 
chloroform). The values of Ɛ correlated with both 
the dielectric constants [17] and polarity indices 
[18] of the solvents in which the reaction was 
performed; correlation coefficients were (r) = 
0.801 and 0.858 for dielectric constants and 
polarity indices, respectively. This was attributed 
to the complete electron transfer from CRB 
(electron donor; D) to DDQ (electron acceptor; A) 
that took place in the polar solvents. Among all 
the solvents tested, acetonitrile offered the 
highest Ɛ value. This was attributed to its high 
dielectric constant that promoted maximum yield 
of radical anion of DDQ, in addition to its high 
solvating power for both DDQ and CRB.  
 
The relatively low value of the association 
constant was attributed to the common feature 
for CT complexes with π-acceptors because of 
the dissociation of the original donor-acceptor 
complex to the radical anion [9]. 
 
The standard free energy change (ΔGo) of the 
CT complex is related to its association constant 
and it can be calculated by the following formula 
(equation 3):  
 
ΔGo = − 2.303 RT log Kc …………………… (3) 
 
where ΔGo is the standard free energy change of 
the complex (kcal mol−1), R is the gas constant 
(1.987 calories degree/mole), T is the absolute 
temperature in Kelvin (oC + 273) and Kc is the 
association constant of the complex (l/mole). 
 
Based on the aforementioned successful 
formation of a red-colored CT complex between 
CRB and DDQ, the reaction was used as a basis 
for the development of CT-based photometric 
assay for the pharmaceutical quality control (QC) 
of CRB. The conventional CT-based photometric 
methods are not automated and consequently 
their analysis throughput is low, thus their 
applications in QC laboratories are limited. 
Moreover, these methods suffer from the con-
sumption of large volumes of organic solvents, 
which leads to high analysis cost, and more im-
portantly, the incidence of exposure of the 
analysts to the toxic effects of the organic 
solvents [19-23]. Therefore, the present study 
was devoted to employing the CT reaction of 
CRB in the development of novel photometric 
method with high analysis throughput that can 
reduce the consumption of organic solvents in 
the QC of CRB.  
 
In previous studies, Darwish et al [24] 
successfully adopted a microwell plate reader 
equipped with photometric detection in the 
development of high-throughput photometric 
assays for measuring the active drug contents in 
pharmaceutical preparations. For these reasons, 
the present study was designed to employ this 
methodology for CRB; the reaction was carried 




This is the first report on the description of the 
CT reaction between CRB and DDQ. The as-say 
provides a high analytical throughput that can 
facilitate the processing of a large number of 
samples in a relatively short time. This property 
is attributed to the use of multi-channel pipettes 
for efficient dispensing of the solutions, carrying 
out the analytical reaction in 96 - well plates (as 
reaction vessels), and measuring the color 
signals in the 96 wells at ~ 30 s by the plate 
reader. In addition, the assay can reduce the 
consumption of organic solvents, thus reducing 
the exposure of analysts to the toxic effects of 
organic solvents, and will lead to lowering of 
analysis cost when the method employed in 
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